Skip to main content
OpenTrials
Completed

NCT Number: NCT04219410

Assessment of a Modified Minimally Invasive Esophagectomy

This is a retrospective case series of a novel fully minimally invasive esophagectomy procedure for patients with primary esophageal cancer.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Esophageal Cancer Digestive System Diseases Digestive System Neoplasms Esophageal Diseases Esophageal Neoplasms Gastrointestinal Diseases Gastrointestinal Neoplasms Head and Neck Neoplasms Neoplasms Neoplasms by Site

Age range

18 year–99 year

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patient with primary esophageal cancer of any cell type
  • underwent the novel minimally invasive esophagectomy procedure at the Kaiser Permanente Northern California Oakland Medical Center by one of the study author-surgeons

Exclusion criteria

  • non-elective procedure
  • less than 90 days of post-discharge follow-up

Treatment and study plan

Fully minimally invasive esophagectomy

Procedure

Esophagectomy using a novel fully minimally invasive approach

Primary outcomes

  1. Hospital length of stay

    Time frame: Through study completion, an average of 2.9 years

    Hospital length of stay

Secondary outcomes

  1. Intensive care unit length of stay

    Time frame: Through study completion, an average of 2.9 years

    Intensive care unit length of stay

  2. Feeding tube placement

    Time frame: Intra-operatively

    Feeding tube placement

  3. Number of patients with inpatient mortality

    Time frame: Through study completion, an average of 2.9 years

    Number of patients with inpatient mortality

  4. 90-day total mortality

    Time frame: 90 days post discharge

    90-day total mortality

  5. Number of patients with hospital readmission within 30 days

    Time frame: 30 days post discharge

    Number of patients with hospital readmission within 30 days

  6. Number of patients with complications

    Time frame: Hospital stay and 30 days post discharge

    Number of patients with medical and surgical complications both inpatient and post-discharge

Sponsors and collaborators

Lead sponsor

Kaiser Permanente

Other

Registry information

Important dates

Study start
2013
Primary completion
2016
Study completion
2016
First posted
Jan 7, 2020
Registry last updated
Jan 7, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.